Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1 1

Status

Recruiting 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 5

Conditions

Nasopharyngeal Carcinoma 15Triple Negative Breast Neoplasms 12Carcinoma, Non-Small-Cell Lung 10Esophageal Squamous Cell Carcinoma 8Breast Neoplasms 8Colorectal Neoplasms 7Carcinoma, Renal Cell 7Small Cell Lung Carcinoma 6Neoplasms 6Advanced Solid Tumor 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Urinary Bladder Neoplasms 4Recurrence 4Head and Neck Neoplasms 4Carcinoma, Hepatocellular 4Stomach Neoplasms 3Solid Tumor 3Neoplasm Metastasis 3Liver Neoplasms 3Carcinoma, Transitional Cell 3Turcot syndrome 2Sarcoma 2Oropharyngeal Neoplasms 2NSCLC 2Muscle Invasive Bladder Cancer (MIBC) 2Carcinoma, Squamous Cell 2Advanced Solid Tumors 2Advanced Lung Cancer 2Advanced Breast Cancer 2

Interventions

pembrolizumab 139Cisplatin 76Cetuximab 53Carboplatin 50Paclitaxel 40Nivolumab 40Radiotherapy 38Docetaxel 34Radiotherapy, Intensity-Modulated 30Magnetic Resonance Spectroscopy 25Fluorouracil 21Specimen Handling 20Platinum 141,2-diaminocyclohexaneplatinum II citrate 13Taxes 12cemiplimab 11Radiation 11Ipilimumab 11Drug Therapy 11atezolizumab 10Surgical Procedures, Operative 10tislelizumab 9Biopsy 9durvalumab 8Radiosurgery 8Chemoradiotherapy 8Albumin-Bound Paclitaxel 8Standard of Care 7130-nm albumin-bound paclitaxel 7Immune Checkpoint Inhibitors 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × toripalimab × 1 year × Clear all
NCT06378177 2026-05-19

A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)

Lyvgen Biopharma Holdings Limited

Phase 2 Active not recruiting
64 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07423078 2026-04-13

WOLF

University of Pittsburgh

Phase 2 Recruiting
87 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT05635643 2026-03-19

Study of CHS-114 in Participants With Advanced Solid Tumors

Coherus Oncology, Inc.

Phase 1 Recruiting
87 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasms

NCT07371897 2026-01-28

SHINE

Sun Yat-sen University

Phase 3 Not yet recruiting
154 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07088211 2025-07-31

Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase 2 Recruiting
39 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡